Binnopharm Group, LLC is one of the leading pharmaceutical companies in Russia with manufacturing facilities in various regions across the country under single management. The Group has branches in 8 countries. The Group’s products are available in 13 countries.

As of 2022, Binnopharm Group was among the Top 10 pharmaceutical corporations in the retail market and ranked 2^nd among domestic drug product manufacturers in the similar segment*. The Group ranks first among the manufacturers of antibiotics in Russia.

Binnopharm Group provides a wide range of quality and affordable prescription and over-the-counter drugs: 450+ marketing authorizations, 200+ pharmacological classes, 370+ million package units annually.

With the creation of one of the country’s most modern R&D centers, Binnopharm Group plans to bring more than 100 new drugs to market by 2025.

*According to AlphaRM, 2022;

**According to IQVIA analytical agency, 2022